BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 22879062)

  • 1. Adenosine signaling in glioma cells.
    Ceruti S; Abbracchio MP
    Adv Exp Med Biol; 2013; 986():13-30. PubMed ID: 22879062
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adenosine Signaling in Glioma Cells.
    Ceruti S; Abbracchio MP
    Adv Exp Med Biol; 2020; 1202():13-33. PubMed ID: 32034707
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Purinergic signaling in glioma progression.
    Braganhol E; Wink MR; Lenz G; Battastini AM
    Adv Exp Med Biol; 2013; 986():81-102. PubMed ID: 22879065
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Autocrine factors that sustain glioma invasion and paracrine biology in the brain microenvironment.
    Hoelzinger DB; Demuth T; Berens ME
    J Natl Cancer Inst; 2007 Nov; 99(21):1583-93. PubMed ID: 17971532
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Signaling pathways regulating gliomagenesis.
    Konopka G; Bonni A
    Curr Mol Med; 2003 Feb; 3(1):73-84. PubMed ID: 12558076
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Suppression of Rac activity induces apoptosis of human glioma cells but not normal human astrocytes.
    Senger DL; Tudan C; Guiot MC; Mazzoni IE; Molenkamp G; LeBlanc R; Antel J; Olivier A; Snipes GJ; Kaplan DR
    Cancer Res; 2002 Apr; 62(7):2131-40. PubMed ID: 11929835
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The excitatory amino acid transporter-2 induces apoptosis and decreases glioma growth in vitro and in vivo.
    de Groot JF; Liu TJ; Fuller G; Yung WK
    Cancer Res; 2005 Mar; 65(5):1934-40. PubMed ID: 15753393
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gene expression for enzymes and transporters involved in regulating adenosine and inosine levels in rat forebrain neurons, astrocytes and C6 glioma cells.
    Parkinson FE; Ferguson J; Zamzow CR; Xiong W
    J Neurosci Res; 2006 Sep; 84(4):801-8. PubMed ID: 16862552
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Block of purinergic P2X7R inhibits tumor growth in a C6 glioma brain tumor animal model.
    Ryu JK; Jantaratnotai N; Serrano-Perez MC; McGeer PL; McLarnon JG
    J Neuropathol Exp Neurol; 2011 Jan; 70(1):13-22. PubMed ID: 21157381
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased Notch Signaling Enhances Radioresistance of Malignant Stromal Cells Induced by Glioma Stem/ Progenitor Cells.
    Shen Y; Chen H; Zhang J; Chen Y; Wang M; Ma J; Hong L; Liu N; Fan Q; Lu X; Tian Y; Wang A; Dong J; Lan Q; Huang Q
    PLoS One; 2015; 10(11):e0142594. PubMed ID: 26599017
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeting malignant glioma survival signalling to improve clinical outcomes.
    Wong ML; Kaye AH; Hovens CM
    J Clin Neurosci; 2007 Apr; 14(4):301-8. PubMed ID: 17276069
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Induction of transforming growth factor-beta1 by basic fibroblast growth factor in rat C6 glioma cells and astrocytes is mediated by MEK/ERK signaling and AP-1 activation.
    Dhandapani KM; Khan MM; Wade FM; Wakade C; Mahesh VB; Brann DW
    J Neurosci Res; 2007 Apr; 85(5):1033-45. PubMed ID: 17335076
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of genetically engineered herpes simplex viruses as oncolytic agents for human malignant brain tumors.
    Andreansky S; Soroceanu L; Flotte ER; Chou J; Markert JM; Gillespie GY; Roizman B; Whitley RJ
    Cancer Res; 1997 Apr; 57(8):1502-9. PubMed ID: 9108452
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ezrin immunoreactivity is associated with increasing malignancy of astrocytic tumors but is absent in oligodendrogliomas.
    Geiger KD; Stoldt P; Schlote W; Derouiche A
    Am J Pathol; 2000 Dec; 157(6):1785-93. PubMed ID: 11106550
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Calcium signaling in glioma cells--the role of nucleotide receptors.
    Wypych D; Pomorski P
    Adv Exp Med Biol; 2013; 986():61-79. PubMed ID: 22879064
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differences between phosphotyrosine accumulation and Neu/ErbB-2 receptor expression in astrocytic proliferative processes. Implications for glial oncogenesis.
    Kristt DA; Yarden Y
    Cancer; 1996 Sep; 78(6):1272-83. PubMed ID: 8826951
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sphingolipid rheostat alterations related to transformation can be exploited for specific induction of lysosomal cell death in murine and human glioma.
    Mora R; Dokic I; Kees T; Hüber CM; Keitel D; Geibig R; Brügge B; Zentgraf H; Brady NR; Régnier-Vigouroux A
    Glia; 2010 Aug; 58(11):1364-83. PubMed ID: 20607862
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tumoral RANKL activates astrocytes that promote glioma cell invasion through cytokine signaling.
    Kim JK; Jin X; Sohn YW; Jin X; Jeon HY; Kim EJ; Ham SW; Jeon HM; Chang SY; Oh SY; Yin J; Kim SH; Park JB; Nakano I; Kim H
    Cancer Lett; 2014 Oct; 353(2):194-200. PubMed ID: 25079688
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protease-activated receptor-1 in human brain: localization and functional expression in astrocytes.
    Junge CE; Lee CJ; Hubbard KB; Zhang Z; Olson JJ; Hepler JR; Brat DJ; Traynelis SF
    Exp Neurol; 2004 Jul; 188(1):94-103. PubMed ID: 15191806
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Macrophage migration inhibitory factor (MIF) expression in human malignant gliomas contributes to immune escape and tumour progression.
    Mittelbronn M; Platten M; Zeiner P; Dombrowski Y; Frank B; Zachskorn C; Harter PN; Weller M; Wischhusen J
    Acta Neuropathol; 2011 Sep; 122(3):353-65. PubMed ID: 21773885
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.